Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Microinflammation is more intense in smaller hair follicles and may be linked to hair loss.

Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.

Many factors, like patient health and how PRP is made, can affect how well PRP therapy works in skin treatments.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Low-dose oral minoxidil may cause side effects like hypertrichosis and is not suitable for everyone.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Scalp-to-scalp skin grafts quickly heal and hide well under regrown hair, making them good for repairing large scalp defects.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Hair loss link to severe COVID-19 unclear.

Minoxidil and spironolactone improve hair density and reduce shedding in girls.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

There's no significant genetic link between male pattern baldness and COVID-19.

No strong proof that platelet-rich plasma effectively treats hair loss.

Hair loss link to COVID-19 severity likely due to other factors.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

PRP injections increased hair density in men with hair loss but didn't work for everyone and more research is needed.

Sparse hairs below frontal hairline can indicate early male balding.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Early hair loss may be linked to metabolic syndrome.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Researchers improved a skin disease diagnosis model using online images, achieving up to 49.64% accuracy.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.